[Endocrinology, what's new in 2016].

Area of Science:

• Endocrinology
• Clinical Guidelines
• Medical Management

Background:

• The European Society of Endocrinology (ESE) has issued updated guidelines.
• These cover critical endocrine conditions: hypoparathyroidism, adrenal incidentalomas, and phaeochromocytoma/paraganglioma (PPGL).

Purpose of the Study:

• To summarize the key recommendations from the ESE guidelines.
• To provide clinicians with updated evidence-based strategies for managing these endocrine disorders.

Main Methods:

• The guidelines were developed by expert panels.
• Recommendations are based on a review of current scientific literature and clinical practice.

Main Results:

• For hypoparathyroidism, focus is on screening for chronic complications and monitoring calcium/vitamin D. Recombinant PTH is noted as a future option.
• Adrenal incidentalomas evaluation prioritizes non-contrast CT to assess malignancy risk.
• Post-surgery phaeochromocytoma/paraganglioma (PPGL) management requires individualized follow-up based on recurrence risk.

Conclusions:

• The ESE guidelines offer a comprehensive framework for managing hypoparathyroidism, adrenal incidentalomas, and PPGL.
• Adherence to these guidelines can optimize patient care and outcomes.